Concepedia

Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT study

Kunal Mahajan, Raman Puri, P. Barton Duell, Deep Dutta, Rahul Yadav, Surender Kumar, Jai Bharat Sharma, Prashant Patel, Savio Dsouza, Ashu Gupta,

Journal of clinical lipidology · 2024 · 15 citations · 5 references

DOI

Concepts

References

5

Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)

Konstantinos C. Koskinas, Stephan Windecker, Giovanni Pedrazzini et al. · Journal of the American College of Cardiology · 2019 · 275 citations · Full text

, , +16

Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries – Findings from the EUROASPIRE IV survey

Željko Reiner, Guy De Backer, Zlatko Fras et al. · Atherosclerosis · 2016 · 210 citations · Full text

, , +16

Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial

John Rubino, Diane MacDougall, Lulu Ren Sterling et al. · Atherosclerosis · 2020 · 91 citations

, , +13

Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort study

Amit Kaura, Adam Hartley, Vasileios F. Panoulas et al. · PLoS Medicine · 2022 · 49 citations · Full text

, , +16

Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of India

Vimal Mehta, P. Barton Duell, S. S. Iyengar et al. · Journal of clinical lipidology · 2022 · 20 citations

, , +16